Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (231-240 of 721) with videos related to

Pageof 73
Sort By:
American Journal of Nuclear Medicine and Molecular Imaging|June 13, 2015
Influence of CT-based attenuation correction on dopamine transporter SPECT with [(123)I]FP-CITConstantin Lapa, Timo S Spehl, Joachim Brumberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2021
Just another "Clever Hans"? Neural networks and FDG PET-CT to predict the outcome of patients with breast cancerManuel Weber, David Kersting, Lale Umutlu, et al.
Seminars in Nuclear Medicine|March 16, 2024
Imaging of Cardiac Fibrosis: How Far Have We Moved From Extracellular to Cellular?Tugce Telli, Atefeh Hosseini, Stephan Settelmeier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 26, 2020
Semiautomatically Quantified Tumor Volume Using <sup>68</sup>Ga-PSMA-11 PET as a Biomarker for Survival in Patients with Advanced Prostate CancerRobert Seifert, Ken Herrmann, Jens Kleesiek, et al.
Head & Neck|December 31, 2013
Freehand SPECT-guided sentinel lymph node biopsy in early oral squamous cell carcinomaChristina Bluemel, Ken Herrmann, Urs Müller-Richter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 14, 2007
Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDGAmbros J Beer, Sylvie Lorenzen, Stephan Metz, et al.
Nuklearmedizin. Nuclear Medicine|March 28, 2019
Changing trends of incidence and prognosis of thyroid carcinomaJamshid Farahati, Uwe Mäder, Elena Gilman, et al.
The Lancet. Oncology|November 4, 2021
Nuclear medicine theranostics comes of ageKen Herrmann, Bernd Joachim Kraus, Boris Hadaschik, et al.
JACC. Cardiovascular Imaging|December 25, 2015
[(68)Ga]Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial InfarctionConstantin Lapa, Theresa Reiter, Rudolf A Werner, et al.
EJNMMI Physics|July 20, 2018
Quantitative performance of <sup>124</sup>I PET/MR of neck lesions in thyroid cancer patients using <sup>124</sup>I PET/CT as referenceWalter Jentzen, Jinda Phaosricharoen, Benedikt Gomez, et al.
Pageof 73

Showing results (231-240 of 721) with videos related to

Sort By:
Pageof 73
American Journal of Nuclear Medicine and Molecular Imaging|June 13, 2015
Influence of CT-based attenuation correction on dopamine transporter SPECT with [(123)I]FP-CITConstantin Lapa, Timo S Spehl, Joachim Brumberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2021
Just another "Clever Hans"? Neural networks and FDG PET-CT to predict the outcome of patients with breast cancerManuel Weber, David Kersting, Lale Umutlu, et al.
Seminars in Nuclear Medicine|March 16, 2024
Imaging of Cardiac Fibrosis: How Far Have We Moved From Extracellular to Cellular?Tugce Telli, Atefeh Hosseini, Stephan Settelmeier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 26, 2020
Semiautomatically Quantified Tumor Volume Using <sup>68</sup>Ga-PSMA-11 PET as a Biomarker for Survival in Patients with Advanced Prostate CancerRobert Seifert, Ken Herrmann, Jens Kleesiek, et al.
Head & Neck|December 31, 2013
Freehand SPECT-guided sentinel lymph node biopsy in early oral squamous cell carcinomaChristina Bluemel, Ken Herrmann, Urs Müller-Richter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 14, 2007
Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDGAmbros J Beer, Sylvie Lorenzen, Stephan Metz, et al.
Nuklearmedizin. Nuclear Medicine|March 28, 2019
Changing trends of incidence and prognosis of thyroid carcinomaJamshid Farahati, Uwe Mäder, Elena Gilman, et al.
The Lancet. Oncology|November 4, 2021
Nuclear medicine theranostics comes of ageKen Herrmann, Bernd Joachim Kraus, Boris Hadaschik, et al.
JACC. Cardiovascular Imaging|December 25, 2015
[(68)Ga]Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial InfarctionConstantin Lapa, Theresa Reiter, Rudolf A Werner, et al.
EJNMMI Physics|July 20, 2018
Quantitative performance of <sup>124</sup>I PET/MR of neck lesions in thyroid cancer patients using <sup>124</sup>I PET/CT as referenceWalter Jentzen, Jinda Phaosricharoen, Benedikt Gomez, et al.
Pageof 73